CONTENTS:
- Social media as pharmacovigilance: The potential for patient reports to inform clinical research on Glucagon-Like Peptide 1 (GLP-1) receptor agonists for substance use disorders. Bremmer M.P., Hendershot C.S., p. 5-11.
- Causation and common liability in the progression of the U.S. opioid crisis. Dash G.F., Conlin W.E., Winograd R.P., p. 12-18.
- Pronounced state-level disparities in Medicaid prescribing of buprenorphine for opioid use disorder (2019-2020). Dana S.R., Nichols S.D., McCall K.L., Piper B.J., p. 19-25.
- Telehealth-based contingency management targeting stimulant abstinence: A case series from the COVID-19 pandemic. Forster S.E., Torres T.M., Steinhauer S.R., Forman S.D., p. 26-31.
- Disparities in Alcoholics Anonymous participation from 2000 to 2020 among U.S. residents with an alcohol use disorder in the National Alcohol Survey. Zemore S.E., Mericle A.A., Martinez P., Bergman B.G., Karriker-Jaffe K.J., Patterson D., et al., p. 32-40.
- Change in alcohol consumption in adolescence and emerging adulthood: A meta-analysis. Pinquart M., p. 41-50.
- Alcohol-related problems as moderators of PTSD symptom change during use of a web-based intervention for hazardous drinking and PTSD. Polizzi C.P., Sistad R.E., Livingston N.A., Brief D., Litwack S., Roy M., et al., p. 51-61.
- Characterizing alcohol consumption and positive and negative consequences during simultaneous alcohol and cannabis use events. Boyle H.K., Jackson K.M., Carey K.B., Merrill J.E., p. 62-72.
- A dual-process decision-making model examining the longitudinal associations between alcohol-induced blackouts and alcohol use disorder risk among college student drinkers. Glenn S.D., Turrisi R.J., Richards V.L., Russell M.A., Mallett K.A., p. 73-83.
- Examining alcohol-related blackouts and drinking motives over time among college women. Ward R.M., Geyer R., Cleveland M., Perlman E., Messman T., p. 84-91.
- Self-reported substance use with clinician interviewers versus self-administered surveys. Gorfinkel L., Stohl M., Shmulewitz D., Hasin D., p. 92-99.
- Cannabis retailer communication about cannabis products, health benefits, and risks: A mystery shopper study of licensed retailers in five U.S. cities. Romm K.F., Cavazos-Rehg P.A., Williams R., Dopke C., Cui Y., LoParco C.R., et al., p. 100-108.
- The impacts of selling alcohol in grocery stores in Ontario, Canada: A before-after study. Schwartz N., Smith B.T., Fu S.H., Myran D., Friesen E.L., Hobin E., p. 109-119.
- Estimating the effects of hypothetical alcohol minimum unit pricing policies on alcohol use and deaths: A state example. Bertin L., Leung G., Bohm M.K., LeClercq J., Skillen E.L., Esser M.B., p. 120-132.
- Apologizing for the alcohol industry? A comment on ISFAR's defense of alcohol's purported health benefits. Stockwell T., Zhao J., Naimi T., p. 133-135.
- ISFAR reiterates its defense of moderate alcohol consumption's health benefits. Stockley C.S., Hendriks H.F.J., Ellison R.C., p. 136-140.
- Judgment-based errors in epidemiological studies: A commentary on Stockley et al. (2024) and Stockwell et al. (2024). Shield K., Rehm J., p. 141-142.
- Moving beyond trench warfare: The need for further hypothesis testing about whether observed health benefits from alcohol consumption are genuine. Stockwell T., Zhao J., Clay J.M., Sherk A., Naimi T., p. 143-146.
- A response from friends of NIAAA to Babor (2023) and Mitchell and McCambridge (2023). Wieczorek W.F., p. 147.